The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox
Open accessAbstract
Adipocytes produce adipokines, including chemerin, a chemoattractant that mediates effects through its ChemR23 receptor. Chemerin has been linked to endothelial dysfunction and vascular injury in pathological conditions, such as obesity, diabetes mellitus, and hypertension. Molecular mechanisms underlying this are elusive. Here we assessed whether chemerin through redox-sensitive signaling influences molecular processes associated with vascular growth, apoptosis, and inflammation. Human microvascular endothelial cells and vascular smooth muscle cells were stimulated with chemerin (50 ng/mL). Chemerin increased generation of reactive oxygen species and phosphorylation of mitogen-activated protein kinases, effects that were inhibited by ML171, GKT137831 (Nox inhibitors), and N-acetylcysteine (reactive oxygen species scavenger). Chemerin increased mRNA expression of proinflammatory mediators in vascular cells and increased monocyte-to-endothelial cell attachment. In human vascular smooth muscle cells, chemerin induced phosphorylation of mitogen-activated protein kinases and stimulated proliferation (increased proliferating cell nuclear antigen expression [proliferation marker] and BrdU incorporation [proliferation assay]). Chemerin decreased phosphatidylinositol 3-kinase/protein kinase B activation and increased TUNEL-positive human vascular smooth muscle cells. In human microvascular endothelial cells, chemerin reduced endothelial nitric oxide synthase activity and nitric oxide production. Adipocyte-conditioned medium from obese/diabetic mice (db/db), which have elevated chemerin levels, increased reactive oxygen species generation in vascular smooth muscle cells, whereas adipocyte-conditioned medium from control mice had no effect. Chemerin actions were blocked by CCX 832, a ChemR23 inhibitor. Our data demonstrate that chemerin, through Nox activation and redox-sensitive mitogen-activated protein kinases signaling, exerts proapoptotic, proinflammatory, and proliferative effects in human vascular cells. These findings elucidate some molecular mechanisms through chemerin, which is increased in obesity, whereby adipocytes may influence vascular function. We identify chemerin as a novel vasoactive adipokine, which may be important in obesity-related vascular injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chemerin is a chemotactic molecule for M1-like macrophages114, exerts pro-inflammatory effects and increases the production of reactive oxygen species in vascular cells120.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288
Wittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030382 · Cited by 888
Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism
Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., Parlee, S. D., Muruganandan, S., & Sinal, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700793200 · Cited by 867
Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome
Bozaoglu, K., Bolton, K. A., McMillan, J. S., Zimmet, P., Jowett, J. B. M., Collier, G. R., Walder, K. R., & Segal, D. (2007) · Endocrinology · doi:10.1210/en.2007-0175 · Cited by 859
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434
Chemerin: at the crossroads of inflammation and obesity
Ernst, M. C., & Sinal, C. J. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.001 · Cited by 431
Sell, H., Laurencikiene, J., Taube, A., Eckardt, K., Cramer, A., Horrighs, A., Arner, P., & Eckel, J. (2009) · Diabetes · doi:10.2337/db09-0277 · Cited by 387
Cited by
Sorted by citations
Items 101–113 of 113
Chemerin/ChemerinR1 axis and inflammation-related diseases
Li, J., Mao, C., Li, K., Huang, Y., Yang, Y., Li, K., Li, S., & Wen, L. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1785693 · Cited by 1
Giannopoulou, V., Papavassiliou, K. A., Lotsios, N. S., Kardara, M., Kotanidou, Α., Papavassiliou, A. G., Dimopoulou, I., & Vassiliou, A. G. (2026) · Biomedicines · doi:10.3390/biomedicines14071553 · Cited by 1
Premature vascular aging and senescence in chronic kidney disease
Ebert, T., & Stenvinkel, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00012-3 · Cited by 1
Neves, K. B. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2016.tde-05102016-091840
Self-citationChanges of Chemerin Production in Obese Patients with Different States of Carbohydrate Metabolism
Василенко, М. А., Кириенкова, Е. В., Skuratovskaia, D., Затолокин, П. А., Mironyuk, N. I., & Litvinova, L. S. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750818010110
Association of Chemerin with Complications in type 2 diabetic patients.
Perswani, P., Kumar, R., Sandesh, R., Fatima, S. M., & Zaidi, S. M. (2019) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v6i10.06
Regulation of physiological and tumoral angiogenesis by the chemerin system
Dhaou, C. B. (2021) · theses.fr (ABES) · doi:10.70675/b20f44c6z3697z4ba4za667z4fea3db4f273
Light wavelength and duration modulate visfatin, chemerin and oxidative status in broilers
Koç, E., Kaya, M., Fidan, E. D., Boyacıoğlu, M., & Aykoç, M. (2026) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2026.107042
Wen, L., Li, S., Xia, X., Huang, Y., Yang, Y., Li, K., Li, J., Xu, M., Liu, C., Liu, G., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124613
Tissue-Specific Chemerin in Atherosclerosis
Chen, M., Li, Y., Linling, F., & Liu, L. (2026) · Biomolecules · doi:10.3390/biom16091327
Fogacci, F., D’Addato, S., Glogowski, P. A., Ragazzini, M., Ciocia, A., Borghi, C., Cicero, A. F. G., & the Brisighella Heart Study Group (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188264
Chaurasiya, V., Pham, D. D., & Olkkonen, V. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1957205
Metadata
- Authors
- Neves, K. B., Nguyen Dinh Cat, A., Lopes, R. A. M., Rios, F. J., Anagnostopoulou, A., Lobato, N. S., de Oliveira, A. M., Tostes, R. C., Montezano, A. C., & Touyz, R. M.
- Affiliations
- Universidade de São Paulo (BR)
- From the Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, College of Medicine, Veterinary and Life Sciences, University of Glasgow (K.B.N., A.N.D.C., R.A.M.L., F.J.R., A.A., A.C.M., R.M.T.); Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirao Preto (K.B.N., A.M.d.O.) and Department of Pharmacology (R.A.M.L., R.C.T.), University of Sao Paulo, Ribeirao Preto, SP, Brazil; and Department of Biological Sciences, Federal...
- Corresponding author
- Touyz, Rhian M.
- ORCID
- Venue
- Hypertension
- Published
- 2015-09
- Volume
- 66
- Issue
- 3
- Pages
- 657-666
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2152629111
- Cited by
- 113
- References
- 51
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 8 · 2019: 16 · 2018: 12 · 2017: 14 · 2016: 8 · 2015: 4
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
- Funders
- British Heart Foundation (29762, RG/13/7/30099, 30099)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- chemerin, NADPH oxidase, adipocytes, vascular smooth muscle cells, microvascular endothelial cells, reactive oxygen species, MAPK signaling, apoptosis, inflammation, cell proliferation, endothelial nitric oxide synthase, nitric oxide, adipokines, obesity, vascular injury, type 2 diabetes
- MeSH terms
- Cell Communication, Endothelium, Vascular, Humans, Muscle, Smooth, Vascular, Phosphorylation, Apoptosis, Reactive Oxygen Species, Adipocytes, Chemokines, Myocytes, Smooth Muscle, Intercellular Signaling Peptides and Proteins, Endothelial Cells, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
